Evidence map›Paper›PMID 28636910›Full record

ArticleBiophysical journal2017

Prp40 Homolog A Is a Novel Centrin Target.

Adalberto Díaz Casas, Walter J Chazin, Belinda Pastrana-Ríos

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Binding by calmodulin is coupled to transient unfolding of the third FF domain of Prp40A.Protein science : a publication of the Protein Society · 2023
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Adalberto Díaz CasasDepartment of Chemistry, University of Puerto Rico Mayagüez Campus, Mayagüez, Puerto Rico.
Walter J ChazinDepartment of Biochemistry and Chemistry, Center for Structural Biology, Vanderbilt University, Nashville, Tennessee.
Belinda Pastrana-RíosDepartment of Chemistry, University of Puerto Rico Mayagüez Campus, Mayagüez, Puerto Rico; Protein Research Center, University of Puerto Rico Mayagüez Campus, Mayagüez, Puerto Rico. Electronic address: belinda.pastrana@upr.edu.
University of Puerto Rico-Mayaguez · PRVanderbilt University · US

Funding

Unraveling the Reaction between Heme (FeIV=O) Moiety and H2SS06GM008103 · NIGMS · UNIVERSITY OF PUERTO RICO MAYAGUEZ · PI PASTRANA-RIOS, BELINDA · 1989 to 2010
$10.6M
MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Structural Biology of Multi-Domain Proteins and Multi-Protein Machinery in DNA Replication and RepairR35GM118089 · NIGMS · VANDERBILT UNIVERSITY · PI WALTER J. CHAZIN · 2016 to 2026
$4.9M
NIGMS NIH HHS R35 GM118089NIGMS NIH HHS S06 GM008103NIGMS NIH HHS T32 GM008320
6 · The paper itself

Abstract

Pre-mRNA processing protein 40 (Prp40) is a nuclear protein that has a role in pre-mRNA splicing. Prp40 possesses two leucine-rich nuclear export signals, but little is known about the function of Prp40 in the export process. Another protein that has a role in protein export is centrin, a member of the EF-hand superfamily of Ca

Indexed as

Binding SitesCalorimetryCarrier ProteinsChlamydomonas reinhardtiiCircular DichroismHumansHydrophobic and Hydrophilic InteractionsProtein UnfoldingRecombinant ProteinsSequence Homology, Amino AcidSpectroscopy, Fourier Transform InfraredThermodynamicsTrimethoprim, Sulfamethoxazole Drug CombinationTwo-Hybrid System TechniquesCarrier ProteinsPRPF40A protein, humanRecombinant ProteinsTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID28636910
PMCPMC5479147
OpenAlexW2714119997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.